Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943110 · ClinicalTrials.gov registry record · NA
Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.
A NA study, sponsored by PATH.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01943110 is a NA study that has completed, run by PATH. The registered enrollment target is 30 participants.
The verdict
NCT01943110, a NA study, has completed, sponsored by PATH.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery devices can safely and precisely inject liquid into the intradermal layer of the skin in three different injection locations
Interventions
- DEVICE ID adapter (autodisable)
- DEVICE ID adapter (side load)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-07 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01943110
The ClinicalTrials.gov registry entry for NCT01943110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PATH, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ID adapter (autodisable) is the first listed.
NCT01943110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01943110 about?
NCT01943110 is a clinical study titled "Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.". The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery devices can safely and precisely inject liquid into the intradermal layer of the skin in three different injection locations
What is the current status of trial NCT01943110?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01943110?
The interventions under investigation include: ID adapter (autodisable) (DEVICE), ID adapter (side load) (DEVICE).
Who is sponsoring clinical trial NCT01943110?
This trial is sponsored by PATH, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.